GCM
MRNA icon

Graham Capital Management’s Moderna MRNA Stock Holding History

Graham Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,068
Closed -$802K – 1461
2025
Q3 		$802K Sell
31,068
-86,885
-74% -$2.42M 0.01% 449
2025
Q2 		$3.25M Buy
117,953
+105,717
+864% +$2.78M 0.05% 228
2025
Q1 		$347K Buy
+12,236
New +$434K 0.01% 940
2024
Q4 		– Sell
-10,991
Closed -$735K – 1386
2024
Q3 		$735K Buy
10,991
+1,874
+21% +$172K 0.01% 540
2024
Q2 		$1.08M Buy
9,117
+5,726
+169% +$725K 0.02% 397
2024
Q1 		$361K Sell
3,391
-487
-13% -$49.1K 0.01% 719
2023
Q4 		$386K Buy
+3,878
New +$326K 0.01% 663
2022
Q4 		– Sell
-3,837
Closed -$453K – 1218
2022
Q3 		$453K Buy
3,837
+1,853
+93% +$281K 0.02% 773
2022
Q2 		$283K Buy
+1,984
New +$284K 0.01% 849
2022
Q1 		– Sell
-1,577
Closed -$400K – 975
2021
Q4 		$400K Sell
1,577
-7,220
-82% -$2.11M 0.02% 225
2021
Q3 		$3.38M Buy
+8,797
New +$3.24M 0.17% 61

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Graham Capital Management's MRNA Position: Q4 2025 in Review

Graham Capital Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 31,068 shares — an estimated $802K sold.

Graham Capital Management first reported a position in MRNA in Q3 2021 and held it in 11 quarters. The position peaked at $3.38M in Q3 2021. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Graham Capital Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 31,068 Moderna shares in Q4 2025, an estimated $802K.
  • Graham Capital Management first reported a position in Moderna in Q3 2021 and held it in 11 quarters.
  • Graham Capital Management's Moderna position peaked at $3.38M in Q3 2021.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.